- 1.Kharrazi M, Kharrazi LD. Delayed diagnosis of cystic fibrosis and the family perspective. J Pediatr. 2005; 147(3 Suppl): S21–S25.
10.1016/j.jpeds.2005.08.011 Crossref Medline, Google Scholar - 2.Farrell PM, Kosorok MR, Laxova A, Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med. 1997; 337(14):963–969.
10.1056/NEJM199710023371403 Crossref Medline, Google Scholar - 3.Koscik RL, Lai HJ, Laxova A, Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. J Pediatr. 2005; 147(3 Suppl):S51–S56.
10.1016/j.jpeds.2005.08.003 Crossref Medline, Google Scholar - 4.Mérelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J. 2001; 18(2):306–315.
10.1183/09031936.01.00080101 Crossref Medline, Google Scholar - 5.Waters DL, Wilcken B, Irwing L, Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed. 1999; 80(1):F1–F7.
10.1136/fn.80.1.F1 Crossref Medline, Google Scholar - 6.Grosse SD, Rosenfeld M, Devine OJ, Lai HJ, Farrell PM. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. J Pediatr. 2006; 149(3):362–366.
10.1016/j.jpeds.2006.04.059 Crossref Medline, Google Scholar - 7.Grosse SD, Boyle CA, Botkin JR, Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep. 2004; 53(RR-13):1–36. Google Scholar
- 8.American College of Medical Genetics Newborn Screening Expert Group. Newborn screening: toward a uniform screening panel and system — executive summary. Pediatrics. 2006; 117(5 Pt 2):S296–S307. Medline, Google Scholar
- 9.Sontag MK, Wright D, Beebe J, Accurso FJ, Sagel SD. A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA. J Pediatr. 2009; 155(5):618–622.
10.1016/j.jpeds.2009.03.057 Crossref Medline, Google Scholar - 10.Farrell PM, Rosenstein BJ, White TB, ; Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008; 153(2):S4–S14.
10.1016/j.jpeds.2008.05.005 Crossref Medline, Google Scholar - 11.Cystic Fibrosis FoundationBorowitz D, Parad RB, Sharp JK, Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr. 2009; 155(6 Suppl):S106–S116.
10.1016/j.jpeds.2009.09.003 Crossref Medline, Google Scholar - 12.Cystic Fibrosis FoundationBorowitz D, Robinson KA, Rosenfeld M, Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009; 155(6 Suppl):S73–S93.
10.1016/j.jpeds.2009.09.001 Crossref Medline, Google Scholar - 13.Sontag MK, Hammond KB, Zielenski J, Wagener JS, Accurso FJ. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. J Pediatr. 2005; 147(3 Suppl):S83–S88.
10.1016/j.jpeds.2005.08.005 Crossref Medline, Google Scholar - 14.Konstan MW, Butler SM, Wohl ME, , Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr. 2003; 142(6):624–630.
10.1067/mpd.2003.152 Crossref Medline, Google Scholar - 15.Walkowiak J, Sands D, Nowakowska A, Piotrowski R, Zybert K, Herzig KH, Milanowski A. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations. J Pediatr Gastroenterol Nutr. 2005; 40(2):199–201.
10.1097/00005176-200502000-00022 Crossref Medline, Google Scholar - 16.Feranchak AP, Sontag MK, Wagener JS, Hammond KB, Accurso FJ, Sokol RJ. Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr. 1999; 135(5):601–610.
10.1016/S0022-3476(99)70059-4 Crossref Medline, Google Scholar - 17.Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr. 1995; 127(5):681–684.
10.1016/S0022-3476(95)70153-2 Crossref Medline, Google Scholar - 18.Colombo C, Costantini D, Zazzeron L, Benefits of breastfeeding in cystic fibrosis: a single-centre follow-up survey. Acta Paediatr. 2007; 96(8):1228–1232.
10.1111/j.1651-2227.2007.00397.x Crossref Medline, Google Scholar - 19.Holliday KE, Allen JR, Waters DL, Gruca MA, Thompson SM, Gaskin KJ. Growth of human milk-fed and formula-fed infants with cystic fibrosis. J Pediatr. 1991; 118(1):77–79.
10.1016/S0022-3476(05)81850-5 Crossref Medline, Google Scholar - 20.Ellis L, Kalnins D, Corey M, Brennan J, Pencharz P, Durie P. Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study. J Pediatr. 1998; 132(2):270–276.
10.1016/S0022-3476(98)70444-5 Crossref Medline, Google Scholar - 21.Farrell PM, Mischler EH, Sondel SA, Palta M. Predigested formula for infants with cystic fibrosis. J Am Diet Assoc. 1987; 87(10):1353–1356. Crossref Medline, Google Scholar
- 22.Canciani M, Mastella G. Absorption of a new semielemental diet in infants with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1985; 4(5):735–740.
10.1097/00005176-198510000-00009 Crossref Medline, Google Scholar - 23.Powers SW, Patton SR, Byars KC, Caloric intake and eating behavior in infants and toddlers with cystic fibrosis. Pediatrics. 2002; 109(5):E75–E75.
10.1542/peds.109.5.e75 Crossref Medline, Google Scholar - 24.Farrell PM, Li Z, Kosorok MR, Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr Pulmonol. 2003; 36(3):230–240.
10.1002/ppul.10336 Crossref Medline, Google Scholar - 25.Long FR, Williams RS, Castile RG. Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr. 2004; 144(2):154–161.
10.1016/j.jpeds.2003.09.026 Crossref Medline, Google Scholar - 26.Weaver LT, Green MR, Nicholson K, Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period. Arch Dis Child. 1994; 70(2):84–89.
10.1136/adc.70.2.84 Crossref Medline, Google Scholar - 27.Smyth A, Walters S. Prophylactic antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2003;(3):CD001912. Medline, Google Scholar
- 28.Ratjen F, Munck A, Kho P. Short and long-term efficacy of inhaled tobramycin in early P. aeruginosa infection: the ELITE study. Pediatr Pulm. 2008; (Suppl 31):319. Google Scholar
- 29.Flume PA, O’Sullivan BP, Robinson KA, Cystic Fibrosis Foundation, Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007; 176(10):957–969.
10.1164/rccm.200705-664OC Crossref Medline, Google Scholar - 30.Martínez TM, Llapur CJ, Williams TH, High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis. Am J Respir Crit Care Med. 2005; 172(9):1133–1138.
10.1164/rccm.200412-1665OC Crossref Medline, Google Scholar - 31.Linnane BM, Hall GL, Nolan G, AREST-CF. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med. 2008; 178(12):1238–1244.
10.1164/rccm.200804-551OC Crossref Medline, Google Scholar - 32.Saiman L, Siegel JCystic Fibrosis Foundation. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol. 2003; 24(5 Suppl):S6–S52.
10.1086/503485 Crossref Medline, Google Scholar - 33.Button BM, Heine RG, Catto-Smith AG, Chest physiotherapy in infants with cystic fibrosis: to tip or not? A five-year study. Pediatr Pulmonol. 2003; 35(3):208–213.
10.1002/ppul.10227 Crossref Medline, Google Scholar - 34.Jones AP, Wallis CE. Recombinant human deoxyribonuclease for cystic fibrosis. Cochrane Database Syst Rev. 2003;(3): CD001127. Medline, Google Scholar
- 35.Dellon EP, Donaldson SH, Johnson R, Davis SD. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis. Pediatr Pulmonol. 2008; 43(11):1100–1106.
10.1002/ppul.20909 Crossref Medline, Google Scholar
